It also has implications for female BRCA1 mutation carriers, as it appears that oral contraceptive use is associated with a reduction in risk of ovarian cancer, the more deadly consequence of their genetic heritage [24]. This evidence concerns the gene BRCA1 and ovarian carcinoma.